Biomarkers in community-acquired pneumonia : a state-of-the-art review

dc.contributor.author	Seligman, Renato	pt_BR
dc.contributor.author	Lima, Luís Francisco Ramos	pt_BR
dc.contributor.author	Oliveira, Vivian do Amaral	pt_BR
dc.contributor.author	Sanvicente, Carina Tôrres	pt_BR
dc.contributor.author	Pacheco, Elyara Fiorin	pt_BR
dc.contributor.author	Dalla Rosa, Karoline Gabriela	pt_BR
dc.date.accessioned	2014-12-25T02:10:09Z	pt_BR
dc.date.issued	2012	pt_BR
dc.identifier.issn	1807-5932	pt_BR
dc.identifier.uri	http://hdl.handle.net/10183/108663	pt_BR
dc.description.abstract	Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biological and clinical features of biomarkers in CAP patients, including procalcitonin, C-reactive protein, copeptin, pro-ANP (atrial natriuretic peptide), adrenomedullin, cortisol and D-dimers.	en
dc.format.mimetype	application/pdf
dc.language.iso	eng	pt_BR
dc.relation.ispartof	Clinics. São Paulo. Vol. 67, n. 11 (2012), p. 1321-1325	pt_BR
dc.rights	Open Access	en
dc.subject	Pneumonia	pt_BR
dc.subject	Pneumonia	en
dc.subject	Biomarcadores	pt_BR
dc.subject	Biological markers	en
dc.subject	Infecções comunitárias adquiridas	pt_BR
dc.subject	Community-acquired infections	en
dc.title	Biomarkers in community-acquired pneumonia : a state-of-the-art review	pt_BR
dc.type	Artigo de periódico	pt_BR
dc.identifier.nrb	000875364	pt_BR
dc.type.origin	Nacional	pt_BR

Este item está licenciado na Creative Commons License